Federal contract

VA awarded McKesson Corporation a contract with $1.4B committed so far.

$1.4B
committed so far
Signed
May 1, 2026
Updated
Jul 1, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 7, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  2. Feb 1, 2026Federal contract · $1.1B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.06B obligated to date
  3. Feb 4, 2026CongressDisclosed purchase of MCK — reported range $15,001 - $50,000
  4. Mar 1, 2026Federal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.18B obligated to date
  5. Mar 2, 2026InsiderOfficer sold ~$2.7M of MCK shares in the open market
  6. Mar 3, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 3, 2026, Britt J. Vitalone, the company’s Executive Vice President and Chief Financial Officer, gave notice of his intention to retire from that role. Mr. Vitalone’s last day as our CFO will be May 28, 2026, and he will remain an employee through July 1, 2026.”
  7. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  8. Mar 27, 2026CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  9. Apr 1, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  10. Apr 1, 2026Federal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.19B obligated to date
  11. Apr 8, 2026CongressDisclosed partial sale of MCK — reported range $1,001 - $15,000
  12. Apr 28, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
  13. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  14. May 1, 2026 · this disclosureFederal contract · $1.4B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.4B obligated to date

What came next

  1. May 7, 2026Company filing · Form 8-K · ResultsReported its results
  2. May 26, 2026Insider · 2 peopleInsiders: 2 sales (~$4.5M)
  3. Jun 1, 2026Federal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.19B obligated to date
  4. Jun 1, 2026Insider · 2 peopleInsiders: 2 sales (~$1.4M)
  5. Jun 2, 2026InsiderOfficer sold ~$514K of MCK shares in the open market
  6. Jun 5, 2026InsiderOfficer sold ~$102K of MCK shares in the open market
  7. Jun 9, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  8. Jun 9, 2026InsiderCEO sold ~$3.76M of MCK shares in the open market
  9. Jun 10, 2026FDARecall: Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH…
  10. Jun 15, 2026CongressDisclosed sale of MCK — reported range $1,001 - $15,000
  11. Jun 17, 2026InsiderCEO sold ~$6.56M of MCK shares in the open market
  12. Jun 29, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 29, 2026, Thomas L. Rodgers, the company’s Executive Vice President, Chief Strategy and Business Development Officer and a named executive officer, gave notice of his intention to retire from that role.”
  13. Jul 7, 2026InsiderCEO sold ~$6.72M of MCK shares in the open market
  14. Jul 8, 2026CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  15. Aug 3, 2026Government · Federal Register ruleStreamlining Probationary and Trial Period Appeals
  16. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
  17. Aug 10, 2026InsiderDirector sold ~$269K of MCK shares in the open market
View the official recordUSAspending.gov award record

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for McKesson Corporation

For McKesson Corporation, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 47 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCK page.

How this filing works

Other disclosures at McKesson Corporation

Everything OQRO holds on this company is on its MCK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data